NCT02862652 2026-01-21
THROMBLEUKEMIA
CHU de Reims
Phase NA Completed
Clinical Trials
12 trialsNCT07041827 2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
NCT06093334 2024-12-17
MinimALL
University of Erlangen-Nürnberg Medical School
Phase NA Completed
NCT02819128 2023-04-21
SDF
Assistance Publique Hopitaux De Marseille
Phase NA Completed
NCT02640287 2021-08-06
WAL-KU
Central Hospital, Nancy, France
Phase NA Completed
NCT01916135 2020-04-27
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02041611 2018-06-27
Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT00569309 2018-03-12
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT02260414 2017-05-11
METRO B
Centre Hospitalier Universitaire de Saint Etienne
Phase 2 Completed
NCT01471067 2017-04-28
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00989586 2017-02-06
Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 1/2 Completed
NCT00590941 2013-05-16
Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma
Washington University School of Medicine
Phase NA Completed